265 related articles for article (PubMed ID: 17674155)
1. Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging.
Kim SH; Csaky KG; Wang NS; Lutz RJ
Pharm Res; 2008 Mar; 25(3):512-20. PubMed ID: 17674155
[TBL] [Abstract][Full Text] [Related]
2. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
Kim SH; Galbán CJ; Lutz RJ; Dedrick RL; Csaky KG; Lizak MJ; Wang NS; Tansey G; Robinson MR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):808-14. PubMed ID: 17251481
[TBL] [Abstract][Full Text] [Related]
3. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
4. Structure and Size-selective Permeability of the Synovial Membrane of the Temporomandibular Joint of the Mouse Measured by MR Imaging at 7T.
Yamazaki F; Satoh K; Seo Y
Magn Reson Med Sci; 2015; 14(2):115-22. PubMed ID: 25500776
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
6. MRI study of subconjunctival and intravitreal injections.
Li SK; Hao J; Liu H; Lee JH
J Pharm Sci; 2012 Jul; 101(7):2353-63. PubMed ID: 22473517
[TBL] [Abstract][Full Text] [Related]
7. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents.
Schwitter J; Saeed M; Wendland MF; Derugin N; Canet E; Brasch RC; Higgins CB
J Am Coll Cardiol; 1997 Oct; 30(4):1086-94. PubMed ID: 9316544
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
9. A simple and inexpensive system for controlling body temperature in small animal experiments using MRI and the effect of body temperature on the hepatic kinetics of Gd-EOB-DTPA.
Murase K; Assanai P; Takata H; Saito S; Nishiura M
Magn Reson Imaging; 2013 Dec; 31(10):1744-51. PubMed ID: 24094686
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-enhanced 7.0 T magnetic resonance imaging assessment of the aqueous inflow in rat eyes in vivo.
Li L; Yuan Y; Chen L; Li M; Ji P; Gong J; Zhao Y; Zhang H
Exp Eye Res; 2017 Sep; 162():18-26. PubMed ID: 28655605
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
Wang X; Feng Y; Ke T; Schabel M; Lu ZR
Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
[TBL] [Abstract][Full Text] [Related]
12. Effect of ependymal and pial surfaces on convection-enhanced delivery.
Jagannathan J; Walbridge S; Butman JA; Oldfield EH; Lonser RR
J Neurosurg; 2008 Sep; 109(3):547-52. PubMed ID: 18759589
[TBL] [Abstract][Full Text] [Related]
13. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of Gd-DTPA and HSA-Gd-DTPA in magnetic resonance lymphography].
Wu YK; Fang TS; Chen DC; Liu GQ; Xu YK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1597-600. PubMed ID: 17959548
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses.
Veldhoen S; Oechsner M; Fischer A; Weng AM; Kunz AS; Bley TA; Köstler H; Ritter CO
Invest Radiol; 2016 Mar; 51(3):186-93. PubMed ID: 26606550
[TBL] [Abstract][Full Text] [Related]
16. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.
Wallnöfer EA; Thurner GC; Kremser C; Talasz H; Stollenwerk MM; Helbok A; Klammsteiner N; Albrecht-Schgoer K; Dietrich H; Jaschke W; Debbage P
Histochem Cell Biol; 2021 Jan; 155(1):19-73. PubMed ID: 33040183
[TBL] [Abstract][Full Text] [Related]
17. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
[TBL] [Abstract][Full Text] [Related]
18. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
Zangos S; Hammerstingl R; Mack MG; Straub R; Engelmann K; Eichler K; Balzer T; Vogl TJ
Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
[TBL] [Abstract][Full Text] [Related]
19. Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced blood-brain barrier opening and concurrent MR and ultrasound imaging.
Liao AH; Liu HL; Su CH; Hua MY; Yang HW; Weng YT; Hsu PH; Huang SM; Wu SY; Wang HE; Yen TC; Li PC
Phys Med Biol; 2012 May; 57(9):2787-802. PubMed ID: 22510713
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]